361 related articles for article (PubMed ID: 17852158)
61. Outpatient clinic for users of anabolic androgenic steroids: an overview.
Smit DL; de Ronde W
Neth J Med; 2018 May; 76(4):167. PubMed ID: 29845939
[TBL] [Abstract][Full Text] [Related]
62. Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes.
Christou GA; Christou MA; Žiberna L; Christou KA
Eur J Sport Sci; 2019 Oct; 19(9):1276-1286. PubMed ID: 30880613
[TBL] [Abstract][Full Text] [Related]
63. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
Santos AM; da Rocha MS; da Silva MF
Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
[TBL] [Abstract][Full Text] [Related]
64. Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding.
Vorona E; Nieschlag E
Minerva Endocrinol; 2018 Dec; 43(4):476-488. PubMed ID: 29463075
[TBL] [Abstract][Full Text] [Related]
65. Doping and effects of anabolic androgenic steroids on the heart: histological, ultrastructural, and echocardiographic assessment in strength athletes.
Hassan NA; Salem MF; Sayed MA
Hum Exp Toxicol; 2009 May; 28(5):273-83. PubMed ID: 19755459
[TBL] [Abstract][Full Text] [Related]
66. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
[TBL] [Abstract][Full Text] [Related]
67. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program.
Goldberg L; Elliot D; Clarke GN; MacKinnon DP; Moe E; Zoref L; Green C; Wolf SL; Greffrath E; Miller DJ; Lapin A
JAMA; 1996 Nov; 276(19):1555-62. PubMed ID: 8918852
[TBL] [Abstract][Full Text] [Related]
68. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes.
Luijkx T; Velthuis BK; Backx FJ; Buckens CF; Prakken NH; Rienks R; Mali WP; Cramer MJ
Int J Cardiol; 2013 Aug; 167(3):664-8. PubMed ID: 22459398
[TBL] [Abstract][Full Text] [Related]
69. Levels of aggression among a group of anabolic-androgenic steroid users.
Midgley SJ; Heather N; Davies JB
Med Sci Law; 2001 Oct; 41(4):309-14. PubMed ID: 11693226
[TBL] [Abstract][Full Text] [Related]
70. The assessment of liver function test and fertility hormones in Saudi athletes using anabolic androgenic steroids.
Jambi S; Mirza A; Zughaibi T; Khalil H; Borai A
Saudi Pharm J; 2024 Feb; 32(2):101954. PubMed ID: 38292405
[TBL] [Abstract][Full Text] [Related]
71. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
[TBL] [Abstract][Full Text] [Related]
72. Diagnosis and Management of Anabolic Androgenic Steroid Use.
Anawalt BD
J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
[TBL] [Abstract][Full Text] [Related]
73. [Cardiovascular side effects of anabolic-androgenic steroids].
Kindermann W
Herz; 2006 Sep; 31(6):566-73. PubMed ID: 17036188
[TBL] [Abstract][Full Text] [Related]
74. Anabolic-androgenic steroid use among Brazilian bodybuilders.
Nogueira FR; Brito Ade F; Oliveira CV; Vieira TI; Gouveia RL
Subst Use Misuse; 2014 Jul; 49(9):1138-45. PubMed ID: 24832911
[TBL] [Abstract][Full Text] [Related]
75. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland.
Rachoń D; Pokrywka L; Suchecka-Rachoń K
Soz Praventivmed; 2006; 51(6):392-8. PubMed ID: 17658145
[TBL] [Abstract][Full Text] [Related]
76. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids.
Smith DA; Perry PJ
Ann Pharmacother; 1992 Apr; 26(4):520-8. PubMed ID: 1533554
[TBL] [Abstract][Full Text] [Related]
77. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
78. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
Hartgens F; Cheriex EC; Kuipers H
Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
[TBL] [Abstract][Full Text] [Related]
79. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.
Achar S; Rostamian A; Narayan SM
Am J Cardiol; 2010 Sep; 106(6):893-901. PubMed ID: 20816133
[TBL] [Abstract][Full Text] [Related]
80. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents.
Hallgren M; Pope HG; Kanayama G; Hudson JI; Lundin A; Källmén H
Eur Addict Res; 2015; 21(6):321-6. PubMed ID: 26113433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
